Javier Briones

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Mark P. Chao, Ash A. Alizadeh, Chad Tang et al. · Cell · 2010 · 1K citations · Full text

Lymphoid Neoplasia, Cancer Immunosurveillance, Immunology +6

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Alexandra Valera, Armando López‐Guillermo, Teresa M. Cardesa‐Salzmann et al. · Haematologica · 2013 · 225 citations · Full text

Immunology, Pathology, Myc Amplifications +16

Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry

Sandra Quijano, Antonio López, Juan‐Manuel Sancho et al. · Journal of Clinical Oncology · 2009 · 214 citations · Full text

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

Ash A. Alizadeh, Andrew J. Gentles, Alvaro J. Alencar et al. · Blood · 2011 · 204 citations